The combination of a cancer vaccine and T-cell therapy proves beneficial for advanced ovarian cancer patients by leveraging the immune system against cancer cells. The vaccine stimulates the immune system, teaching it to recognize and target specific tumor markers. T-cell therapy involves collecting and modifying a patient’s T cells to enhance their cancer-fighting abilities. Together, these treatments boost the immune response, targeting cancer cells more effectively, potentially slowing tumor growth and improving patient outcomes.
